Health network views Velano’s technology as a way to further demonstrate commitment to patient and practitioner-centered care
Sacramento, Calif. and San Francisco, Calif., November 29, 2016 – The not-for-profit Sutter Health network is among the first in the country—and the first in California—to offer patients a novel needle-free blood draw technology from Velano Vascular.
The PIVO™ vascular access device is an innovative solution to the age-old challenge of consistently drawing high quality blood samples with less discomfort and anxiety for hospitalized patients while enhancing safer care for practitioners.
“Blood draws are a near universal experience in healthcare – a critical procedure that can cause emotional trauma for some patients,” said Sutter Health Chief Innovation Officer Chris Waugh. “Every moment matters while patients are in our care. If we can help make them feel more comfortable and at ease, then we are creating a healing experience at all levels. Our collaboration with Velano Vascular is the first step of what we envision will be a ground-breaking journey toward a new industry-wide standard of more compassionate care in blood draws.”
Sutter Health looked to Velano’s simple, elegant system design to provide a more compassionate experience for patients with improved outcomes and a safer, more efficient environment for practitioners. The FDA-cleared PIVO device uses a patient’s existing peripheral IV line to transform blood collection standards and reduce hospitals’ reliance on needle sticks and central line access for blood draws.
“It’s important for us at Sutter Health to continually research and explore new ways of enhancing quality of care and how we deliver that care,” said Sutter Health Chief Nursing Officer Anna Kiger, DNP, D.Sc., MBA, R.N. “By removing the needle from the equation using the PIVO device, we aim to create a more positive patient-practitioner relationship, to deliver safer care and to bring important efficiencies to this vital procedure.”
Sutter Health will evaluate the PIVO device as an initial step in an anticipated broader rollout of this novel procedure, building upon Sutter Health’s investment in Velano’s Series A-2 financing earlier this year.
“We are thrilled to be working with Sutter Health as an institution widely recognized for embracing new models of innovation and improved care delivery,” said Velano Vascular Chief Executive Eric M. Stone. “Sutter’s commitment to human-centered design reflects a natural alignment with Velano, forming the foundation for a united effort to establish a safer, more efficient standard of care for patients and practitioners.”
About Sutter Health
Serving patients and their families in more than 100 Northern California cities and towns, Sutter Health doctors, not-for-profit hospitals and other healthcare service providers share resources and expertise to advance health care quality and access. The Sutter Medical Network includes many of California’s top-performing, highest-quality physician organizations as measured annually by the Integrated Healthcare Association. Sutter-affiliated hospitals are regional leaders in cardiac care, women’s and children’s services, cancer care, orthopedics and advanced patient-safety technology. Sutter Health cares for more than 3 million people—nearly 1 percent of the U.S. population. For more information about the not-for-profit Sutter Health network visit: sutterhealth.org, facebook.com/sutterhealth, youtube.com/sutterhealth, twitter.com/sutterhealth.
About Velano Vascular
Velano Vascular is a medical device company committed to reducing the pain, risk, and inefficiencies of vascular access and blood collection practices. The company’s revolutionary PIVO device enables needle free blood draws directly from Peripheral IV catheters, aiming to enable more compassionate care for hospital inpatients, a safer practice for caregivers, and a more financially responsible alternative for health systems. Velano Vascular is backed by a series of well-respected investment firms, health systems, and dozens of health-industry veterans. Company collaborators include several of the leading hospital systems in the United States. More information is available at www.velanovascular.com and @velanovascular
